FDA shuffles top drug, biologics leaders in latest shakeup
The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.
By · May 16, 2026 · 1 min read
This article was originally published by
CNBC Top News
and is republished here under license.
The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.
Leave a Reply